• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home 2020

Post Archive by Year

Juvenile xanthogranuloma: retrospective analysis of 44 pediatric cases (single tertiary care center experience).

In Dermatology
by ClinOwl
December 10, 2020

Juvenile xanthogranuloma (JXG) is a rarely encountered skin disorder, which is characterized by the proliferation of non-Langerhans cell histiocytes. As JXG primarily affects infants and young children, this study aims …

View Post

Sildenafil, Trazodone Tablets Recalled After Being Packaged Together

In HealthDay News
by Healthday
December 10, 2020

AvKARE says it is not aware of any patients being harmed by the recalled products

Trends in Body Mass Index Before and After Diagnosis of Hidradenitis Suppurativa.

In Dermatology
by ClinOwl
December 10, 2020

Temporal relationship between HS and obesity is not established.To compare baseline BMI and change in BMI between HS patients and controls before and after diagnosis.Retrospective case-control analysis of 1,284 HS …

Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after anti-TNF failure.

In Dermatology
by ClinOwl
December 10, 2020

Dear Editor, hidradenitis suppurativa (HS) is a relapsing inflammatory skin disease. The cytokines IL-1β, IL-12, IL-23, IL-17 and TNF-α are involved in the inflammatory process. The only approved drug for …

View Post

COVID-19 Vaccine Caution Issued by U.K. Officials

In HealthDay News
by Healthday
December 9, 2020

Warning issued after two people suffered adverse reactions on the first day of the U.K. mass vaccination program

Cepharanthine induces the proliferation of human dermal papilla cells and stimulates VEGF expression through increased intracellular calcium mobilization and HIF activation.

In Dermatology
by ClinOwl
December 9, 2020

Cepharanthine (CEP), which is extracted from Stephania cephalantha, is commonly prescribed to treat alopecia areata; however, the scientific evidence for its efficacy is limited.To investigate the effect of CEP and …

View Post

Radiological Society of North America, Nov. 29-Dec. 5

In HealthDay News
by Healthday
December 9, 2020

The 106th Scientific Assembly and Annual Meeting of the Radiological Society of North America

View Post

Canada Approves Pfizer COVID-19 Vaccine

In HealthDay News
by Healthday
December 9, 2020

Health Canada completed a full independent review of the data on the vaccine’s safety and effectiveness

View Post

Over Half of Obese Patients Have Diabetes Remission After RYGB

In HealthDay News
by Healthday
December 9, 2020

Remission rates greater in younger participants and those with short diabetes duration, higher HOMA percentage B

Clinical efficacy of popular oral hair growth supplement ingredients.

In Dermatology
by ClinOwl
December 9, 2020

Hair supplements are a vast and growing industry. Patients often turn to oral supplements to address hair concerns as they are easily accessible. There are numerous products on the market, …

  • Page 25 of 126
  • ←
  • 1
  • ...
  • 24
  • 25
  • 26
  • ...
  • 126
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Mar    

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer